Novel bromomelatonin derivatives suppress osteoclastic activity and increase osteoblastic activity: Implications for the treatment of bone diseases

Nobuo Suzuki, Masanori Somei, Kei Ichiro Kitamura, Russel J. Reiter, Atsuhiko Hattori

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Novel bromomelatonin derivatives suppress osteoclastic activity and increase osteoblastic activity: Implications for the treatment of bone diseases'. Together they form a unique fingerprint.

Medicine & Life Sciences